Table of Contents Author Guidelines Submit a Manuscript
Erratum

An erratum for this article has been published. To view the erratum, please click here.

Evidence-Based Complementary and Alternative Medicine
Volume 2011 (2011), Article ID 450529, 8 pages
http://dx.doi.org/10.1093/ecam/nep230
Original Article

Study of the Anti-Proliferative Activity of 5-Substituted 4,7-Dimethoxy-1,3-Benzodioxole Derivatives of SY-1 from Antrodia camphorata on Human COLO 205 Colon Cancer Cells

1Department of Chemistry, Tunghai University, Taichung, Taiwan
2Yusheng Biotechnology Co. Ltd., Taichung, Taiwan
3Institute of Biochemistry, College of Life Science, National Chung Hsing University, Taichung, Taiwan
4Department of Life Science, National Chung Hsing University, Taichung, Taiwan
5Department of Applied Chemistry, Chung Shan Medical University, No. 110, Sec. 1, Jianguo N. Rd., Taichung 402, Taiwan
6Department of Biochemistry, Chung Shan Medical University Hospital, Taichung, Taiwan

Received 27 July 2009; Accepted 25 November 2009

Copyright © 2011 Hsiu-Man Lien et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. R. Asmis and L. Saltz, “Systemic therapy for colon cancer,” Gastroenterology Clinics of North America, vol. 37, no. 1, pp. 287–295, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Durai, S. Y. Yang, A. M. Seifalian, and M. C. Winslet, “Principles and applications of gene therapy in colon cancer,” Journal of Gastrointestinal and Liver Diseases, vol. 17, no. 1, pp. 59–67, 2008. View at Google Scholar · View at Scopus
  3. T. Kuwai, T. Nakamura, T. Sasaki et al., “Targeting the EGFR, VEGFR, and PDGFR on colon cancer cells and stromal cells is required for therapy,” Clinical and Experimental Metastasis, vol. 25, no. 4, pp. 477–489, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. H. M. Lien, H. W. Lin, Y. J. Wang et al., “Inhibition of anchorage-independent proliferation and G0/G1 cell-cycle regulation in human colorectal carcinoma cells by 4,7-dimethoxy-5-methyl-1,3-benzodioxole isolated from the fruiting body of Antrodia camphorate,” Evidence-Based Complementary and Alternative Medicine, 2009. View at Publisher · View at Google Scholar
  5. K. Neuhaus-Carlisle, W. Vierling, and H. Wagner, “Calcium-channel blocking activity of essential oils from Petroselinum crisp., Api graveolens and isolated phenylpropane constituents,” Pharmaceutical and Pharmacological Letters, vol. 3, pp. 77–79, 1993. View at Google Scholar
  6. A. A. Shahat, G. El-Barouty, R. A. Hassan, F. M. Hammouda, F. H. Abdel-Rahman, and M. A. Saleh, “Chemical composition and antimicrobial activities of the essential oil from the seeds of Enterolobium contortisiliquum (leguminosae),” Journal of Environmental Science and Health B, vol. 43, no. 6, pp. 519–525, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. A. A. Ali and M. T. Ibrahim, “Behavioral effects of essential oil from Salvia aegyptiaca in rats,” Mansoura Journal of Pharmaceutical Sciences, vol. 23, pp. 72–86, 2007. View at Google Scholar
  8. J. Begum, M. Yusuf, J. U. Chowdhury et al., “Composition and antifungal activity of essential oil of leaves of Cinnamomum verum Presl. grown in Bangladesh,” Indian Perfumer, vol. 51, pp. 15–18, 2007. View at Google Scholar
  9. N. I. Bhuiyan, J. U. Chowdhury, J. Begum, and M. A. Azim, “Constituents of the essential oils from Caraway (Carum carvi L.) leaves and fruits,” Dhaka University Journal of Science, vol. 56, pp. 247–249, 2008. View at Google Scholar
  10. M. Dahia, H. Laouer, A. N. Chaker, S. Prado, U. J. Meierhenrich, and N. Baldovini, “Chemical composition and antibacterial activity of Pituranthos chloranthus volatile oil,” Natural Product Communications, vol. 2, pp. 1159–1162, 2007. View at Google Scholar
  11. K. Neuhaus-Carlisle, W. Vierling, and H. Wagner, “Screening of plant extracts and plant constituents for calcium-channel blocking activity,” Phytomedicine, vol. 4, no. 1, pp. 67–69, 1997. View at Google Scholar · View at Scopus
  12. K. M. Siddiqui and D. P. Chopra, “Primary and long term epithelial cell cultures from human fetal normal colonic mucosa,” In Vitro, vol. 20, no. 11, pp. 859–868, 1984. View at Google Scholar · View at Scopus
  13. H. Lin, M.-C. Chen, C.-Y. Chiu, Y.-M. Song, and S.-Y. Lin, “Cdk5 regulates STAT3 activation and cell proliferation in medullary thyroid carcinoma cells,” Journal of Biological Chemistry, vol. 282, no. 5, pp. 2776–2784, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. Y.-S. Ho, Y.-J. Wang, and J.-K. Lin, “Induction of p53 and p21/WAF1/CIP1 expression by nitric oxide and their association with apoptosis in human cancer cells,” Molecular Carcinogenesis, vol. 16, no. 1, pp. 20–31, 1996. View at Publisher · View at Google Scholar · View at Scopus
  15. Y.-S. Ho, C.-H. Wu, H.-M. Chou et al., “Molecular mechanisms of econazole-induced toxicity on human colon cancer cells: G0/G1 cell cycle arrest and caspase 8-independent apoptotic signaling pathways,” Food and Chemical Toxicology, vol. 43, no. 10, pp. 1483–1495, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. C. H. Wu, J. H. Jeng, Y. J. Wang et al., “Antitumor effects of miconazole on human colon carcinoma xenografts in nude mice through induction of apoptosis and G0/G1 cell cycle arrest,” Toxicology and Applied Pharmacology, vol. 180, pp. 22–35, 2002. View at Google Scholar
  17. N. A. Thornberry and Y. Lazebnik, “Caspases: enemies within,” Science, vol. 281, no. 5381, pp. 1312–1316, 1998. View at Google Scholar · View at Scopus
  18. W. S. El-Deiry, T. Tokino, V. E. Velculescu et al., “WAF1, a potential mediator of p53 tumor suppression,” Cell, vol. 75, no. 4, pp. 817–825, 1993. View at Publisher · View at Google Scholar · View at Scopus
  19. D. H. Phillips, M. V. Reddy, and K. Randerath, “32P-post-labelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturally-occurring alkenylbenzenes: II Newborn male B6C3F1 mice,” Carcinogenesis, vol. 5, pp. 1623–1628, 1984. View at Google Scholar
  20. K. M. Meepagala, G. Sturtz, D. E. Wedge, K. K. Schrader, and S. O. Duke, “Phytotoxic and antifungal compounds from two Apiaceae species, Lomatium californicum and Ligusticum hultenii, rich sources of Z-ligustilide and apiol, respectively,” Journal of Chemical Ecology, vol. 31, no. 7, pp. 1567–1578, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Jin and A. J. Levine, “The p53 functional circuit,” Journal of Cell Science, vol. 114, no. 23, pp. 4139–4140, 2001. View at Google Scholar · View at Scopus
  22. T. Hunter and J. Pines, “Cyclins and cancer II: cyclin D and CDK inhibitors come of age,” Cell, vol. 79, no. 4, pp. 573–582, 1994. View at Publisher · View at Google Scholar · View at Scopus
  23. D. O. Morgan, “Principles of CDK regulation,” Nature, vol. 374, no. 6518, pp. 131–134, 1995. View at Google Scholar · View at Scopus
  24. C. J. Sherr and J. M. Roberts, “Inhibitors of mammalian G1 cyclin-dependent kinases,” Genes and Development, vol. 9, no. 10, pp. 1149–1163, 1995. View at Google Scholar · View at Scopus
  25. W. Yan, G. Liu, A. Scoumanne, and X. Chen, “Suppression of inhibitor of differentiation 2, a target of mutant p53, is required for gain-of-function mutations,” Cancer Research, vol. 68, no. 16, pp. 6789–6796, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. J. E. Chipuk, T. Kuwana, L. Bouchier-Hayes et al., “Direct activation of bax by p53 mediates mitochondrial membrane permeabilization and apoptosis,” Science, vol. 303, no. 5660, pp. 1010–1014, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Li, H. Zhu, C.-J. Xu, and J. Yuan, “Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis,” Cell, vol. 94, no. 4, pp. 491–501, 1998. View at Google Scholar · View at Scopus